新的检查和治疗方法(NUB)包括新颖的药物,医疗产品和程序,可在达到完全报销资格之前由医院...查看全文
Linktu2021-01-18 09:54
$Neovasc(NVCN)$ 本来盈利的, 突然的利空出来,我被小套一点, 此股有主力在12月份0.70开始介入吸筹,0.85左右是他们的底线,下跌空间已经不大,主力会自救反弹,每次反弹都是极好的T+0机会查看全文
Linktu2021-01-18 09:49
$Neovasc(NVCN)$ 2021年1月15日,宣布收到美国食品药品管理局(FDA)的不可批准的信函,内容涉及其Neovasc Reducer(TM)(Reducer)的PMA提交。查看全文
Linktu2021-01-16 08:48
$Neovasc(NVCN)$ 惨了,坏消息,看公司官方网站公布的消息
FDA审查了Reducer用于治疗难治性心绞痛的患者,这些患者不适合通过冠状动脉搭桥术或经皮冠状动脉介入术进行血运重建。还原剂在欧盟具有CE标记,用于治疗难治性心绞痛。查看全文
$Neovasc(NVCN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-23-044460 Act: 34 Size: 34 KB 网页链接
$Neovasc(NVCN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-23-043866 Act: 34 Size: 4 MB 网页链接
$Neovasc(NVCN)$ RW Registration Withdrawal Request Accession Number: 0001104659-23-043861 Act: NE Size: 7 KB 网页链接
$Neovasc(NVCN)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001104659-23-043856 Act: 33 Size: 22 KB 网页链接
$Neovasc(NVCN)$ POS AM Post-Effective amendments for registration statement Accession Number: 0001104659-23-043857 Act: 33 Size: 25 KB 网页链接
$Neovasc(NVCN)$ F-10POS Post-effective amendment to a F-10EF registration Accession Number: 0001104659-23-043858 Act: 33 Size: 27 KB 网页链接
$Neovasc(NVCN)$ 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities Accession Number: 0001354457-23-000260 Act: 34 Size: 2 KB 网页链接
$Neovasc(NVCN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001062993-23-008995 Act: 34 Size: 27 KB 网页链接
$Neovasc(NVCN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-23-040217 Act: 34 Size: 2 MB 网页链接
$Neovasc(NVCN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-23-030600 Act: 34 Size: 4 MB 网页链接